News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,485 Results
Type
Article (41964)
Company Profile (252)
Press Release (671269)
Multimedia
Podcasts (53)
Webinars (12)
Section
Business (208464)
Career Advice (2103)
Deals (35903)
Drug Delivery (100)
Drug Development (82172)
Employer Resources (176)
FDA (16367)
Job Trends (15086)
News (351595)
Policy (33127)
Tag
Academia (2643)
Accelerated approval (5)
Adcomms (25)
Allergies (85)
Alliances (50393)
ALS (89)
Alzheimer's disease (1396)
Antibody-drug conjugate (ADC) (128)
Approvals (16370)
Artificial intelligence (259)
Autoimmune disease (22)
Automation (16)
Bankruptcy (363)
Best Places to Work (11778)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (177)
Bladder cancer (78)
Brain cancer (28)
Breast cancer (281)
Cancer (2283)
Cardiovascular disease (175)
Career advice (1761)
Career pathing (32)
CAR-T (152)
Cell therapy (432)
Cervical cancer (19)
Clinical research (66828)
Collaboration (843)
Company closure (1)
Compensation (533)
Complete response letters (19)
COVID-19 (2620)
CRISPR (41)
C-suite (251)
Cystic fibrosis (100)
Data (2220)
Decentralized trials (2)
Denatured (21)
Depression (44)
Diabetes (276)
Diagnostics (6499)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (123)
Drug pricing (104)
Drug shortages (25)
Duchenne muscular dystrophy (94)
Earnings (88422)
Editorial (37)
Employer branding (21)
Employer resources (149)
Events (115085)
Executive appointments (735)
FDA (17639)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (757)
Gene editing (105)
Generative AI (20)
Gene therapy (309)
GLP-1 (720)
Government (4509)
Grass and pollen (4)
Guidances (67)
Healthcare (19126)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (116)
Indications (29)
Infectious disease (2764)
Inflammatory bowel disease (140)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (324)
IPO (16705)
IRA (40)
Job creations (3722)
Job search strategy (1498)
Kidney cancer (10)
Labor market (38)
Layoffs (478)
Leadership (20)
Legal (8041)
Liver cancer (76)
Lung cancer (329)
Lymphoma (154)
Machine learning (7)
Management (60)
Manufacturing (310)
MASH (67)
Medical device (13624)
Medtech (13629)
Mergers & acquisitions (19747)
Metabolic disorders (695)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (90)
Neuropsychiatric disorders (27)
Neuroscience (1939)
NextGen: Class of 2025 (6622)
Non-profit (4589)
Now hiring (39)
Obesity (370)
Opinion (214)
Ovarian cancer (75)
Pain (88)
Pancreatic cancer (85)
Parkinson's disease (151)
Partnered (21)
Patents (233)
Patient recruitment (113)
Peanut (46)
People (58593)
Pharmaceutical (66)
Pharmacy benefit managers (18)
Phase I (20807)
Phase II (29404)
Phase III (21918)
Pipeline (1208)
Policy (139)
Postmarket research (2649)
Preclinical (8900)
Press Release (64)
Prostate cancer (106)
Psychedelics (32)
Radiopharmaceuticals (247)
Rare diseases (385)
Real estate (6054)
Recruiting (66)
Regulatory (22679)
Reports (46)
Research institute (2386)
Resumes & cover letters (358)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (71)
Series A (131)
Series B (84)
Service/supplier (11)
Sickle cell disease (53)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (30)
Startups (3633)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (41)
The Weekly (30)
Vaccines (698)
Venture capitalists (41)
Weight loss (241)
Women's health (37)
Worklife (17)
Date
Today (156)
Last 7 days (936)
Last 30 days (2652)
Last 365 days (33057)
2025 (10836)
2024 (35532)
2023 (40488)
2022 (51674)
2021 (56302)
2020 (54766)
2019 (47457)
2018 (35740)
2017 (32833)
2016 (32300)
2015 (38442)
2014 (32127)
2013 (27105)
2012 (29398)
2011 (30031)
2010 (28126)
Location
Africa (764)
Alabama (53)
Alaska (7)
Arizona (236)
Arkansas (13)
Asia (39358)
Australia (6490)
California (6168)
Canada (2020)
China (531)
Colorado (266)
Connecticut (276)
Delaware (149)
Europe (85714)
Florida (913)
Georgia (206)
Idaho (57)
Illinois (542)
India (26)
Indiana (310)
Iowa (11)
Japan (164)
Kansas (105)
Kentucky (24)
Louisiana (10)
Maine (70)
Maryland (906)
Massachusetts (4601)
Michigan (226)
Minnesota (395)
Mississippi (2)
Missouri (86)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (64)
New Jersey (1736)
New Mexico (28)
New York (1754)
North Carolina (1005)
North Dakota (8)
Northern California (2690)
Ohio (207)
Oklahoma (14)
Oregon (34)
Pennsylvania (1380)
Puerto Rico (12)
Rhode Island (33)
South America (1144)
South Carolina (23)
South Dakota (1)
Southern California (2317)
Tennessee (101)
Texas (911)
United States (23320)
Utah (183)
Virginia (147)
Washington D.C. (64)
Washington State (553)
West Virginia (3)
Wisconsin (59)
713,485 Results for "corium international inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Jabil Acquires Pharmaceutics International, Inc. (Pii)
February 4, 2025
·
4 min read
Genetown
Corium Announces Publication of Favorable ADLARITY® (donepezil transdermal system) Skin Irritation Clinical Trial Data
Corium, LLC announced today the publication of data reinforcing that ADLARITY (donepezil transdermal system) demonstrated favorable skin tolerability and adhesion in a placebo-controlled trial with healthy volunteers.
September 12, 2023
·
9 min read
Press Releases
Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025
March 4, 2025
·
4 min read
Press Releases
Eton Pharmaceuticals Out-Licenses International Rights to Increlex®
April 2, 2025
·
3 min read
Business
Corium Pharma Solutions Appoints Mark Sirgo as Chief Executive Officer
Corium Pharma Solutions, Inc. today announced the appointment of Dr. Mark Sirgo as Chief Executive Officer and member of the Board of Directors.
January 17, 2023
·
5 min read
Business
Corium Pharma Solutions Names Two Industry Veterans to its Executive Team
Corium Pharma Solutions, Inc. has named Kevin Ostrander as Chief Business Officer and Dr. Niraj Vasisht as Chief Technology Officer.
February 9, 2023
·
5 min read
Genetown
Corium and Lotus Pharmaceutical Enter into Exclusive License Agreement for Innovative Alzheimer’s Disease Treatment ADLARITY® in Multiple Markets Across Asia
Corium, LLC and Lotus Pharmaceutical announced that the companies have entered into an exclusive Collaboration and License Agreement for ADLARITY®, an innovative Alzheimer’s dementia treatment, in ten markets across Asia.
August 10, 2023
·
8 min read
Press Releases
CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting
April 25, 2025
·
6 min read
Press Releases
Hemostemix PR Inc. Congratulates Luis Munoz Marin International Airport on Achieving CEIV Pharma Certification
February 11, 2025
·
6 min read
Press Releases
KRTL Holding Group Announces KRTL Biotech Inc. Signs MOU with Industria Químico Farmacéutica Sigma Corp. S.R.L. to Pursue Strategic International Merger
March 25, 2025
·
3 min read
1 of 71,349
Next
